Comparison 9. Medication provision: vitamin D analogue vs placebo.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
9.1 Rate of falls	1		Rate Ratio (IV, Fixed, 95% CI)	Subtotals only
9.1.1 Calcitriol vs placebo	1	213	Rate Ratio (IV, Fixed, 95% CI)	0.64 [0.49, 0.82]
9.2 Number of fallers	2		Risk Ratio (IV, Fixed, 95% CI)	Subtotals only
9.2.1 Calcitriol vs placebo	1	213	Risk Ratio (IV, Fixed, 95% CI)	0.54 [0.31, 0.93]
9.2.2 Alfacalcidol vs placebo	1	378	Risk Ratio (IV, Fixed, 95% CI)	0.69 [0.41, 1.17]
9.3 Number of people sustaining a fracture	1		Risk Ratio (IV, Fixed, 95% CI)	Subtotals only
9.3.1 Calcitriol vs placebo	1	246	Risk Ratio (IV, Fixed, 95% CI)	0.60 [0.28, 1.29]
9.4 Number of people developing hypercalcaemia	2	624	Risk Ratio (M‐H, Fixed, 95% CI)	2.49 [1.12, 5.50]